Patent application number | Description | Published |
20090002868 | Read after write enhancement for bit patterned media - A read/write head for use with bit-patterned media detects write synchronization errors between a write clock and the bit-patterned media. In particular, the read/write head writes data to the bit-patterned media using a write clock. The data is then read from the bit-patterned media and used to detect write synchronization errors between the write clock and the location of bit-islands on the bit-patterned media. Based on detected write synchronization errors, the phase associated with the write clock is modified to align the write clock with the location of bit-islands on the bit-patterned media. | 01-01-2009 |
20090002896 | Magnetic writer for patterned media with increased write field - A magnetic writer writes to a magnetic medium including a plurality of tracks that each includes a plurality of isolated magnetic elements for storage of information. The magnetic writer includes a write element having a write element tip having a leading edge, a trailing edge, and first and second side edges extending between the leading edge and the trailing edge. A side shield is proximate the first side edge and no shield is proximate the second side edge. | 01-01-2009 |
20090003144 | Method and system for error checking in a bit-patterned media - A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. A disc drive system for correcting write synchronization errors includes an encoder, non-volatile storage, and decoder device for implementing a parity-based scheme for increased reliability. Data strings being written to the disc drive are combined in an encoder to generate a parity string. The address of the data being written to the disc drive, along with the updated parity string is stored to the non-volatile storage. The data strings are read from the disc drive by the decoder. If uncorrectable errors are identified, the decoder employs the parity string in conjunction with the other data strings written to the disc drive to reconstruct the data string with uncorrectable errors. | 01-01-2009 |
20100020429 | Converting Timing Errors Into Symbol Errors to Handle Write Mis-Synchronization in Bit-Patterned Media Recording Systems - A method includes: writing data to a bit-patterned media at times determined by a clock having a period that is offset from a bit island period by a fixed offset to create one insertion or one deletion approximately within a predetermined number of bit islands, reading the data, and correcting the read data using error correction. An apparatus that implements the method is also provided. | 01-28-2010 |
20110096430 | Converting Timing Errors into Symbol Errors to Handle Write Mis-Synchronization in Bit-Patterned Media Recording Systems - A method includes writing data to a bit-patterned media at times determined by a clock having a period that is offset from a bit island period by a fixed offset to create one insertion or one deletion approximately within a predetermined number of bit islands, reading the data, and correcting the read data using error correction. An apparatus that implements the method is also provided. | 04-28-2011 |
20110249355 | METHOD AND SYSTEM FOR ERROR CHECKING IN BIT-PATTERNED MEDIA - A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. The disc drive system utilizes the identified write synchronization errors for at least one of timing recovery, equalizer training detection, error correction code application, and error recovery. | 10-13-2011 |
20130128372 | METHOD AND SYSTEM FOR ERROR CHECKING IN BIT-PATTERNED MEDIA - A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. A disc drive system for correcting write synchronization errors includes an encoder, non-volatile storage, and decoder device for implementing a parity-based scheme for increased reliability. Data strings being written to the disc drive are combined in an encoder to generate a parity string. The address of the data being written to the disc drive, along with the updated parity string is stored to the non-volatile storage. The data strings are read from the disc drive by the decoder. If uncorrectable errors are identified, the decoder employs the parity string in conjunction with the other data strings written to the disc drive to reconstruct the data string with uncorrectable errors. | 05-23-2013 |
20130141819 | MAGNETIC WRITER FOR PATTERNED MEDIA WITH INCREASED WRITE FIELD - A magnetic writer writes to a magnetic medium including a plurality of tracks that each includes a plurality of isolated magnetic elements for storage of information. The magnetic writer includes a write element having a write element tip having a leading edge, a trailing edge, and first and second side edges extending between the leading edge and the trailing edge. A side shield is proximate the first side edge and no shield is proximate the second side edge. | 06-06-2013 |
20130272104 | WRITER WITH INCREASED WRITE FIELD - A writer includes a magnetic write pole having a leading surface and a trailing surface and a near field transducer peg spaced from the leading surface of the write pole to provide energy assisted recording. A magnetic recording system for writing to and reading from a continuous magnetic medium includes a write element having a write element tip having a leading edge and a trailing edge, and wherein at least one surface of the write element that extends in a cross-track direction on the continuous magnetic medium has no line of symmetry. | 10-17-2013 |
Patent application number | Description | Published |
20110212967 | IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS - The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer. | 09-01-2011 |
20130338134 | SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS - The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer. | 12-19-2013 |
20130345224 | IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS - The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer. | 12-26-2013 |
20140045814 | PYRAZINE DERIVATIVES AS FGFR INHIBITORS - The present invention relates to pyrazine derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer. | 02-13-2014 |
20140243308 | SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3 - The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases. | 08-28-2014 |
20140249132 | USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS - The present application provides methods of treating PI3Kδ related disorders using compounds of Formula I: | 09-04-2014 |
20140315902 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS - The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer. | 10-23-2014 |
20150225375 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS - The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer. | 08-13-2015 |
20150225379 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS - The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer. | 08-13-2015 |
20150225394 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS - The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer. | 08-13-2015 |
20150225401 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS - The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer. | 08-13-2015 |
20150329561 | Amido Compounds And Their Use As Pharmaceuticals - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 11-19-2015 |
Patent application number | Description | Published |
20080255154 | Amido Compounds And Their Use As Pharmaceuticals - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 10-16-2008 |
20090291946 | LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 11-26-2009 |
20090298808 | INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 12-03-2009 |
20110136781 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS - The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. | 06-09-2011 |
20120015928 | Amido Compounds And Their Use As Pharmaceuticals - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 01-19-2012 |
20120122858 | LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 05-17-2012 |
20120165305 | SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3 - The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases. | 06-28-2012 |
20130324515 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS - The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. | 12-05-2013 |
Patent application number | Description | Published |
20090175880 | ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antib | 07-09-2009 |
20090324622 | ANTIBODY VACCINE CONJUGATES AND USES THEREFOR - The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (βhCG) antigen linked to an anti-mannose receptor (MR) antibody. | 12-31-2009 |
20100098704 | Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies. | 04-22-2010 |
20100303816 | ANTIBODIES AGAINST HUMAN MELANOMA-ASSOCIATED CHONDROITIN SULPHATE PROTEOGLYCAN (MCSP) - The present invention provides isolated antibodies (e.g., humanized or human antibodies) that bind to the membrane-proximal domain (MP) of human Melanoma-Associated Chondroitin Sulphate Proteoglycan (MCSP), and are capable of mediating cytolysis of a cell expressing MCSP in the presence of human effector cells or complement. Methods of using such antibodies to induce cytolysis (e.g., ADCC or CDCC) of cells expressing MP-MCSP are also provided. | 12-02-2010 |
20110274685 | ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF - Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies. | 11-10-2011 |
20120213771 | ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF - Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies. | 08-23-2012 |
20120309031 | ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antib | 12-06-2012 |
20130101593 | ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205) - Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies. | 04-25-2013 |
20150337047 | ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF - Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies. | 11-26-2015 |
Patent application number | Description | Published |
20090146104 | ALIGNMENT FACILITIES FOR OPTICAL DYES - Various non-limiting embodiments disclosed herein provide phase-separating polymer systems including a cured polymeric liquid crystal matrix phase and a guest phase including at least one photoactive material where the guest phase separates from the matrix phase during the curing process. Optical elements, including ophthalmic elements and other articles of manufacture including the phase-separating polymer systems are also disclosed. Methods of forming a liquid crystal phase-separating photoactive polymer system are also described. | 06-11-2009 |
20090309076 | PHOTOCHROMIC COMPOUNDS - A photochromic compound is provided, which may be a pyran, an oxazine, or a fulgide. The photochromic compound has at least one substituent Q attached thereto, each Q independently being —N | 12-17-2009 |
20090323011 | MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed. | 12-31-2009 |
20090323012 | LIQUID CRYSTAL COMPOSITIONS COMPRISING MESOGEN CONTAINING COMPOUNDS - Liquid crystal compositions comprising compounds including at least one mesogenic substructure and at least one long flexible segment and a compound selected from a photochromic compound, a dichroic compound and a photochromic-dichroic compound and methods of synthesizing the same and their use in articles of manufacture and ophthalmic devices are disclosed. | 12-31-2009 |
20090326186 | MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed. | 12-31-2009 |
20100014010 | FORMULATIONS COMPRISING MESOGEN CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed. | 01-21-2010 |
20110128457 | ALIGNMENT FACILITIES FOR OPTICAL DYES - Provided are phase-separating polymer systems including a cured polymeric liquid crystal matrix phase and a guest phase including at least one photoactive material where the guest phase separates from the matrix phase during the curing process. Optical elements, including ophthalmic elements and other articles of manufacture including the phase-separating polymer systems are also disclosed. Methods of forming a liquid crystal phase-separating photoactive polymer system are also described. | 06-02-2011 |
20110129678 | Photochromic compounds and compositions - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. Also described herein are methods for preparing certain photochromic compounds, compositions, and articles. | 06-02-2011 |
20110140056 | Indeno-fused ring compounds - The present invention relates to compounds represented by the following Formulas (I) and (II), | 06-16-2011 |
20110143141 | Photochromic compounds and compositions - The present invention relates to compounds represented by the following Formula I, | 06-16-2011 |
20110216273 | MESOGEN-CONTAINING COMPOUNDS - Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of the mesogen-containing compounds and their use in articles of manufacture and ophthalmic devices are also disclosed. | 09-08-2011 |
20120002141 | MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula Ia, | 01-05-2012 |
20120003401 | MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula I, | 01-05-2012 |
20120021144 | MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula I, | 01-26-2012 |
20120027960 | MESOGENIC STABILIZERS - The present invention relates to compounds represented by the following Formula Ic, | 02-02-2012 |
20120126185 | INDENO-FUSED RING COMPOUNDS - The present invention relates to compounds represented by the following Formulas (I) and (II), | 05-24-2012 |
20120156508 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. | 06-21-2012 |
20120156521 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS - Described herein are compounds generally comprising an indeno[2′,3′:3,4]naptho[1,2-b]pyran structure. Such compounds may be useful for their photochromic properties, and be used in certain photochromic compositions. Such compositions may further comprise other photochromic compositions and/or materials. Additionally, such compounds and/or compositions may be suitable for preparing certain photochromic articles. Also described herein are methods for preparing certain photochromic compounds, compositions, and articles. | 06-21-2012 |
20120157677 | LACTONE COMPOUNDS AND MATERIALS MADE THEREFROM - The present invention relates to lactone compounds represented by the following Formulas I and II, and methods of making such lactone compounds. | 06-21-2012 |
20120157678 | METHODS OF MAKING FUSED RING COMPOUNDS - The present invention relates to methods of making fused ring compounds, such as indeno-fused naphthols, and fused ring indenopyran compounds, such as indeno-fused naphthopyrans, that each employ an unsaturated compound represented by the following Formula II. | 06-21-2012 |
20120200907 | PHOTOCHROMIC COMPOUNDS - A photochromic compound is provided, which may be a pyran, an oxazine, or a fulgide. The photochromic compound has at least one substituent Q attached thereto, each Q independently being —N | 08-09-2012 |
20140154514 | PHOTOCHROMIC COMPOUNDS - A photochromic compound is provided, which may be a pyran, an oxazine, or a fulgide. The photochromic compound has at least one substituent Q attached thereto, each Q independently being —N | 06-05-2014 |
20140166948 | INDENO-FUSED RING COMPOUNDS - The present invention relates to compounds represented by the following Formula (II), | 06-19-2014 |
20140256935 | 5,6-RING-SUBSTITUTED NAPHTHOPYRAN COMPOUNDS - The present invention relates to naphthopyran compounds that include at least one compound represented by the following Formulas (I), (II), and (III): | 09-11-2014 |
20140272468 | PHOTOCHROMIC ARTICLES THAT INCLUDE PHOTOCHROMIC-DICHROIC MATERIALS - The present invention relates to photochromic articles that include a substrate and at least one photochromic material that is adapted to change from an unactivated form to an activated form by exposure to radiation substantially in the wavelength range from 380 to 450 nanometers when measured over a range of from 380 to 700 nanometers. The photochromic article is also adapted to retain at least 12 percent of the delta OD measured in the Outdoor Test when tested in the Behind the Windshield Test. The photochromic material can be selected from certain compounds including, for example, fluoranthenoxazines, naphthopyrans, phenanthropyrans, fluoranthenopyrans, and indenonaphthopyrans, which each have bonded thereto at least one chiral or achiral lengthening group that provides the photochromic compound with dichroic properties. The present invention also relates to methods of forming a photochromic article. | 09-18-2014 |
20150141661 | Photochromic Indeno-Fused Ring Pyran Compounds - The present invention relates to photochromic indeno-fused ring pyran compounds represented by the following Formula (I-A): | 05-21-2015 |
20150141662 | Method Of Preparing Fused Ring Indeno Compounds - The present invention relates to methods of preparing fused ring indeno compounds that involves reacting together a dienophile and a lactone compound, in the presence of a catalyst, and a carboxylic acid anhydride. With some embodiments, the fused ring indeno compound is represented by the following Formula (I-A), the dienophile is represented by the following Formula (II-A), and the lactone compound is represented by the following Formula (III-A): | 05-21-2015 |
20150141663 | Fused Ring Indeno Compounds For Preparation Of Photochromic Compounds - The present invention relates to intermediate compounds represented by the following Formula (I-A), | 05-21-2015 |
Patent application number | Description | Published |
20100038593 | Tubular Reactor With Jet Impingement Heat Transfer - A tubular reactor and method for producing a product mixture in a tubular reactor where the tubular reactor comprises an internal catalytic insert having orifices for forming fluid jets for impinging the fluid on the tube wall. Jet impingement is used to improve heat transfer between the fluid in the tube and the tube wall in a non-adiabatic reactor. The tubular reactor and method may be used for endothermic reactions such as steam methane reforming and for exothermic reactions such as methanation. | 02-18-2010 |
20100077944 | COMBUSTION SYSTEM WITH PRECOMBUSTOR - A precombustor having a chamber having a first end and a second end, and an inlet configured to deliver a substantially parallel flow of solid fuel surrounded by oxygen at the first end. The first end further includes a recirculation step and the second end fluidly communicates with a furnace. The inlet and the recirculation step are arranged to form a recirculation zone of at least a portion of the solid fuel and the oxygen. A combustion system and method for operating a combustion system are also disclosed. | 04-01-2010 |
20100077968 | OXY/FUEL COMBUSTION SYSTEM HAVING COMBINED CONVECTIVE SECTION AND RADIANT SECTION - A heat transfer system having a a radiant source, a first heat exchanger configured to permit a first fluid to flow therethrough, and a thermal shield configured to provide controlled radiative heat from the radiant source to the first exchanger. The radiant source is a flame. The thermal shield is a second heat exchanger configured to permit a second fluid to flow therethrough or a non-contact thermal shield fabricated from a material arranged to provide controlled radiative heat exposure from the radiant source to the first exchanger. Oxy/coal combustion systems are also disclosed. | 04-01-2010 |
20100081098 | Combustion System with Precombustor for Recycled Flue Gas - A precombustor system to be used in conjunction with an oxy-fuel burner employing recycled flue gas is disclosed. A method of introducing streams into the precombustor to achieve desired improvements in flame properties is also disclosed. | 04-01-2010 |
20100313604 | Furnace and Process for Controlling the Oxidative State of Molten Materials - A method useful with oxy-fuel combustion and in a furnace which contains molten material, wherein either substoichiometric or superstoichiometric combustion and low velocity injection of fuel and primary and secondary oxidant in an oxy-fuel burner are carried out in an orientation which forms either a reducing or oxidizing atmosphere proximate the molten surface. | 12-16-2010 |
20110154950 | Burner and Method for Processing Oxidizable Materials - Burner assembly for use in industrial heating and melting applications of material susceptible to oxidation at elevated temperatures is comprised of a flow passage of oxidant surrounded by an annular flow passage of fuel whereby the oxidant is substantially contained inside the fuel layer up to at least 5 oxidant nozzle diameters downstream of the burner outlet in order to minimize contact between the oxidant and the furnace load. | 06-30-2011 |
20110194991 | Tubular Reactor With Jet Impingement Heat Transfer - A tubular reactor for producing a product mixture in a tubular reactor where the tubular reactor comprises an internal catalytic insert with cup-shaped structures having orifices for forming fluid jets for impinging the fluid on the tube wall. Jet impingement is used to improve heat transfer between the fluid in the tube and the tube wall in a non-adiabatic reactor. The tubular reactor and method may be used for endothermic reactions such as steam methane reforming and for exothermic reactions such as methanation. | 08-11-2011 |
20110200955 | Liquid Fuel Combustion Process and Apparatus - An apparatus for combustion of a liquid fuel, such as an atomizer or burner, and an associated method using the apparatus for combusting an atomized liquid fuel. The apparatus for combustion has in outer conduit, an inner conduit and a spray tip. The spray tip has a mixing chamber for receiving a liquid fuel and an atomizing gas, and an orifice for discharging the liquid fuel and atomizing gas mixture as an atomized liquid fuel. The inner conduit has external fins where at least some of the external fins contact the inner surface of the spray tip. | 08-18-2011 |
20120055592 | Method of Metal Processing Using Cryogenic Cooling - Described herein are a method, an apparatus, and a system for metal processing that improves one or more properties of a sintered metal part by controlling the process conditions of the cooling zone of a continuous furnace using one or more cryogenic fluids. In one aspect, there is provided a method comprising: providing a furnace wherein the metal part is passed therethough on a conveyor belt and comprises a hot zone and a cooling zone wherein the cooling zone has a first temperature; and introducing a cryogenic fluid into the cooling zone where the cryogenic fluid reduces the temperature of the cooling zone to a second temperature, wherein at least a portion of the cryogenic fluid provides a vapor within the cooling zone and cools the metal parts passing therethrough at an accelerated cooling rate. | 03-08-2012 |
20120122047 | Selective Adjustment of Heat Flux for Increased Uniformity of Heating a Charge Material in a Tilt Rotary Furnace - A method of heating a charge material by controlling heat flux in a tilt rotary furnace is disclosed. Combustion by the burner forms a heat release profile including a high heat flux region. The positioning of the high heat flux region is controllable by providing a controlled amount of secondary or staged oxidant. The burner is configured and controlled to position a region of high heat flux at a position corresponding to an area requiring greater heating, such as the area of maximum charge depth in the furnace to provide substantially uniform melting and heat distribution. | 05-17-2012 |
20120292833 | Heating Method and System for Controlling Air Ingress into Enclosed Spaces - A heating method for heating vessels, the vessels having enclosed spaces therein and controlling air ingress into the enclosed spaces through gaps. The method includes providing a lid structure for the vessel having the enclosed space, the lid structure having a burner assembly mounted therein. The burner is configured to provide a predetermined flame diameter. The vessel and lid structure are mated such that the gap is formed between the vessel and the lid structure. Fuel and oxidant are discharged from the burner assembly under conditions to provide the predetermined flame diameter and impart a flame velocity sufficiently large to create an outward gas flow from the enclosed space through the gap and control air ingress. | 11-22-2012 |
20130095437 | Oxy-Fuel Furnace and Method of Heating Material in an Oxy-Fuel Furnace - An oxy-fuel furnace and method of heating material in an oxy-fuel furnace are disclosed. The method includes combusting oxygen and fuel with an oxy-fuel burner arrangement in the oxy-fuel furnace forming combustion gases, and maintaining a vortex including the combustion gases within a central region of an enclosure of the oxy-fuel furnace. The oxy-fuel burner arrangement includes a plurality of high momentum oxy-fuel burners arranged at an angle to generate the vortex, the angle being greater than 15 degrees but less than 75 degrees with respect to a furnace wall boundary of the enclosure, an angular velocity of greater than 0.07 radians per second, or a combination thereof. The furnace includes an oxy-fuel burner arrangement including at least two high momentum oxy-fuel burners having high shape factor nozzle geometries, and an enclosure. The vortex increases convective heating within the enclosure and uniformity of heating within the enclosure. | 04-18-2013 |
20150247673 | Transient Heating Burner and Method - A transient heating burner including at least two burner elements each having a distribution nozzle configured to flow a fuel, and an annular nozzle surrounding the distribution nozzle and configured to flow an first oxidant, at least one staging nozzle configured to flow a second oxidant, and a controller programmed to independently control the fuel flow to each distribution nozzle such that at least one of the distribution nozzles is active and at least one of the distribution nozzles is passive, wherein an active distribution nozzle fuel flow is greater than an average fuel flow to the distribution nozzles and a passive nozzle fuel flow is less than the average fuel flow, and to control a staging ratio to be less than or equal to about 75%. | 09-03-2015 |
20150267915 | Low-Firing Rate Oxy-Fuel Flat Flame Burner with Oxygen Staging - A flat flame oxy-fuel burner including a gaseous fuel nozzle having a hydraulic diameter D | 09-24-2015 |